Navigation Links
RxElite Announces 3rd Quarter Financials Conference Call
Date:11/20/2007

MERIDIAN, Idaho, Nov. 20 /PRNewswire-FirstCall/ -- RxElite Holdings, Inc., (OTC Bulletin Board: RXEI) a developer, manufacturer, and marketer of specialty generic prescription drug products will hold a conference call to review its financial results for the third quarter ended September 30, 2007, on Tuesday, November 27, 2007, at 2:00 p.m. EST.

The dial-in numbers are: 1-800-567-5900 (Toll Free in USA and Canada) and 1-702-835-5025 (for callers outside USA and Canada).

Participant Access Code: 640989

Callers will be muted upon joining the conference. Press 7 on your telephone to un-mute and ask questions. The call will also be available for subsequent replay on the company's website. To listen via this alternative, go to the Investor Relations page at http://www.rxelite.com.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contact:

Corporate Information

Ph: (208) 288-5550

Toll Free: (800) 414-1901

Fax: (208) 288-1191

Investor Relations

Charlie Forshee, 215-885-4981

investorrelations@rxelite.com

Segue Ventures LLC


'/>"/>
SOURCE RxElite Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. RxElite Files Registration Statement with Securities and Exchange Commission
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2018)... ... October 18, 2018 , ... ... research study demonstrating the company’s automated preclinical image data analysis tool, InVivoAX™, ... The technology finds applications in preclinical imaging of small animal models of ...
(Date:10/17/2018)... ... , ... A new report from The Fenway Institute and ... management of lesbian, bisexual, gay, transgender, questioning, and intersex (LGBTQI) youth in juvenile ... justice system, especially lesbian and bisexual girls and youth of color. It also ...
(Date:10/16/2018)... ... October 16, 2018 , ... Balboa Capital , a ... franchise financing , is now recognized by Massage Envy as an Approved ... and deliver custom-tailored financing programs to Massage Envy franchisees who need funding for ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... its mission to provide simple, easy-to-use software for biopharma companies. By pairing the ... quickly answer those crucial resourcing questions without spending millions of dollars implementing a ...
(Date:10/16/2018)... WILMINGTON, Del. (PRWEB) , ... October 16, 2018 ... ... Counsel of First Healthcare Compliance, an attorney experienced in employment law, writes frequently ... and other publications. Recently, she authored a chapter in the Health Care Compliance ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... ... October 16, 2018 , ... ... and are said to improve productivity and sleep, is joining forces with Singing ... song written by Steven Battey, four-time Grammy-nominated singer/songwriter and performed by Ashanti, features ...
(Date:10/16/2018)... ... October 16, 2018 , ... Citrus Valley Health Partners and ... exciting and inclusive forum on the health care ecosystem of the San Gabriel Valley. ... to foster evidence-based dialogues and actionable solutions aimed at transforming the way health care ...
(Date:10/16/2018)... ... October 16, 2018 , ... Ophthalmic ... in the American Academy of Ophthalmology’s (AAO) annual session. This four day event ... at McCormick Place in Chicago. AAO 2018 is a leading event for the ...
Breaking Medicine Technology: